annb0t
Top 20
Bionomics Ltd
ADELAIDE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (âCNSâ) disorders with high unmet medical need, today released its Appendix 4C â Quarterly Cashflow Report. Highlights during the Quarter ended 30 September 20...
>>> Read more: Quarterly Activities Report for September 2022
ADELAIDE, Australia, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO, Nasdaq: BNOX), (Bionomics or the Company) a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (âCNSâ) disorders with high unmet medical need, today released its Appendix 4C â Quarterly Cashflow Report. Highlights during the Quarter ended 30 September 20...
>>> Read more: Quarterly Activities Report for September 2022
